Cytori Therapeutics Inc (NASDAQ:CYTX)

0.6601
Delayed Data
As of May 22
 -0.0208 / -3.05%
Today’s Change
0.36
Today|||52-Week Range
2.54
+35.07%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$91.9M

Company Description

Cytori Therapeutics, Inc. is a late stage cell therapy company. Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally by improving blood flow, modulating the immune system, and facilitating wound repair. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.

Contact Information

Cytori Therapeutics, Inc.
3020 Callan Road
San Diego California 92121
P:(858) 458-0900
Investor Relations:

Employees

Shareholders

Mutual fund holders7.60%
Other institutional20.49%
Individual stakeholders12.89%

Top Executives

Marc H. HedrickPresident, Chief Executive Officer & Director
Tiago GirĂŁoCFO, Vice President & Head-Investor Relations
Steven KestenChief Medical Officer & Executive Vice President
John K. FraserChief Scientist
Seijiro Norio ShirahamaPresident-Asia Pacific Region

To view my watchlist

Not a member yet?

Sign up now for a free account